Terbutaline sulfate Tablets Rx
Generic Name and Formulations:
Terbutaline sulfate 2.5mg, 5mg; scored tabs.
Various generic manufacturers
Indications for Terbutaline sulfate Tablets:
Asthma. Chronic bronchitis. Emphysema.
12–15yrs: 2.5mg 3 times daily at 6 hour intervals. >15yrs: 2.5–5mg 3 times daily at 6 hour intervals.
Not for management of preterm labor. Avoid excessive use. Diabetes. Cardiac disease. Hypertension. Hyperthyroidism. Seizure disorders. If subject to hypokalemia, monitor potassium. Pregnancy (Cat.B). Nursing mothers.
Avoid other sympathomimetics (except aerosol bronchodilators), MAOIs, tricyclics. Antagonized by β-blockers.
Tachycardia, palpitations, nervousness, tremor, headache, drowsiness, nausea.
Formerly known under the brand names Brethine, Bricanyl.
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Women Frequently Prescribed High Doses of Opioids After Vaginal Delivery
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Prioritizing Rest in Hospital Settings: Poor Sleep Increases Costs, Complications, and Mortality
- Pain Catastrophizing Decreases in Rheumatoid Arthritis After DMARD Initiation
- Addressing Commercial Incentives in the Medical Device Industry
- Cancer Patients Treated With Step III Opioids Often Have Sleep Disturbances
- Low Literacy Self-Management Program for Chronic Pain May Be Effective